On the recordJuly 26, 2021
However, an enforcement case would, at the minimum, give us a framework and a timeline to resolve the COFEPRIS-regulated delays in biotechnology approvals.
Source
congress.govHowever, an enforcement case would, at the minimum, give us a framework and a timeline to resolve the COFEPRIS-regulated delays in biotechnology approvals.
Grassley emphasizes the need for enforcement to resolve biotech approval delays.
Share
More from Chuck Grassley
The Judiciary Committee stands ready to advance President Trump's next Attorney General nominee.
I was offended by what the president said, and I’m disappointed that it would result in personal insults.
He has a strong legal background and has served his country honorably. I believe he will be diligent, capable and a fair jurist.